GASTROESOPHAGEAL JUNCTION CANCER
Clinical trials for GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New surgery aims to save stomach, prevent severe weight loss in cancer patients
Disease control Not yet recruitingThis study is testing a new surgical technique for early-stage cancer in the upper part of the stomach. It compares removing just the cancerous portion of the stomach (which aims to preserve digestive function) against the standard procedure of removing the entire stomach. The ma…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for advanced stomach cancer: pfizer tests promising drug combo
Disease control Not yet recruitingThis study is testing whether a new drug called PF-08634404 works better when combined with standard chemotherapy for people with advanced stomach, esophageal, or gastroesophageal cancers. The trial has two parts: first checking safety and early effectiveness, then directly compa…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Breakthrough trial targets aggressive stomach cancers with new drug combo
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called TST001 to standard chemotherapy and immunotherapy works better for advanced stomach or gastroesophageal junction cancer. It will involve 820 adults whose tumors have a specific marker called Claudin18.2. The goal is…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: PHASE3 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC